The SIMPLAAFY Clinical Trial is studying the safety and effectiveness of different drug treatments after using a device called the WATCHMAN FLX Pro. This device helps prevent strokes. The study is looking at three types of drug treatments:
- *Aspirin only*
- *Reduced dose of non-vitamin K antagonist oral anticoagulant (NOAC)*, which is a type of blood thinner
- *Dual antiplatelet therapy (DAPT)*, which combines two drugs to prevent blood clots
Participants will be randomly assigned to one of these treatments and will stay on it for 12 months.
- Participation Length: 1 year
- Follow-up Visits: Regular check-ups are required
- Eligibility: Must be a good candidate for the WATCHMAN FLX Pro and able to follow study rules
You cannot join if you've had major heart issues or surgeries recently, or if certain health problems like severe liver disease or active infections are present. This study helps researchers learn which treatment works best for people using the WATCHMAN FLX Pro device.
How understandable was the trial content above?
Hard to understand
Easy to understand